Current Atherosclerosis Reports

, Volume 3, Issue 2, pp 163–168

Low-molecular weight heparins in coronary artery disease

  • Dan Hunt


Recently published trials strongly support the use of low-molecular weight heparins in the treatment of unstable coronary syndromes. These agents provide an alternative to heparin that is at least as effective and safe, and does not require intravenous infusions or meticulous monitoring. Although comparative trials are not yet available, the available evidence allows for selection of specific agents in acute management of unstable angina. This review summarizes the current clinical data supporting the use of these agents.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Dan Hunt
    • 1
  1. 1.Section of General Internal MedicineBen Taub General Hospital, Baylor College of MedicineHoustonUSA

Personalised recommendations